Crossmark

Combined targeting of CCL7 and Flt3L to promote the expansion and infiltration of cDC1s in tumors enhances T-cell activation and anti-PD-1 therapy effectiveness in NSCLC

Crossref DOI link: https://doi.org/10.1038/s41423-023-00991-5

Published Online: 2023-03-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dong, Hong-Peng

Li, Ying

Tang, Zhen

Wang, Peng

Zhong, Bo https://orcid.org/0000-0002-3832-2895
Chu, Qian

Lin, Dandan
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (32270951, 31930040)
License Information

Text and Data Mining valid from 2023-03-09

Version of Record valid from 2023-03-09
More Information

Article History

Received: 16 February 2023

Accepted: 20 February 2023

First Online: 9 March 2023

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below